top of page
Insights to inspire Better Portfolio Decisions
Expert perspectives, research, and real-world insights to advance portfolio thinking and smarter pharma decisions.


Reflections on Risk
In many cases, the only risk quantified in development project investment cases is PTRS (Probability of Technical and Regulatory Success). While technical failures are leading reasons for project cancellations, other critical risks often go unaddressed. Here are three additional types of risks we discussed in the presentation: 👉 Operational Risks These include delays in timelines and increases in development costs. Timeline delays harm project value by delaying revenue and p

Magnus Ytterstad
Dec 10, 20242 min read


4 Reasons Why You Should Leverage a SaaS Platform To Manage Your Pharmaceutical Portfolio
The pharmaceutical industry is constantly evolving, driven by technological advances, regulation changes, and shifting market demands. As...

Captario
Apr 10, 20232 min read


Enhancing Pharmaceutical Portfolio Decision Quality Through Decision Maturity
Pharmaceutical decision quality is an essential journey that enables decision-makers to make strategic decisions with confidence....

Captario
Mar 28, 20233 min read


5 Best Practices for Strategic Pharmaceutical Decision-Making
Making the right decisions in pharma is crucial to ensuring the success of projects and portfolio goals. Here are five best practices...

Captario
Mar 20, 20232 min read
bottom of page